If [211At]FAPI1 can selectively accumulate at tumor sites expressing FAP, it can exhibit anti-tumor activity against a broad range of tumors, including breast cancer, given that FAP is also present in the triple-negative subtype (TNBC), where it is implicated in proliferation, migration, and invasion [16,17]. The gene discussed is FAP; the disease is breast carcinoma.